Federal Register / Vol. 87, No. 13 / Thursday, January 20, 2022 / Notices 3109 

SUMMARY OF ESTIMATED ANNUAL BURDEN—POST-EXAMINATION SURVEYS—Continued 

Information collection (IC) description Type of burden 

Estimated 

number of 

respondents 

Estimated 

frequency 

of response 

Estimated time 

per response 

(minutes) 

Total 

estimated 

annual burden 

(hours) 

Total Estimated Annual Burden .............................. ........................... ........................ ........................... ........................ 867 

General Description of Collection: The 

purpose of the surveys is to gauge 

bankers’ views on the effectiveness and 

quality of FDIC Safety and Soundness 

and Consumer Compliance 

examinations, as well as to identify 

ways to improve the examination 

process. Respondents will be asked to 

voluntarily rate the efficiency of the preexamination process; examiners’ 

professionalism and understanding of 

the laws and regulations; the 

examination process; and examination 

report quality. Respondents will also be 

allowed to provide feedback on any 

areas for improvement and will be given 

an option to have someone from the 

FDIC Office of the Ombudsman contact 

the institution confidentially about its 

recent examination or any other matters. 

Interested members of the public may 

obtain a copy of the proposed survey 

questionnaires on the following web 

pages: 

• https://www.fdic.gov/resources/ 

regulations/federal-registerpublications/2022/fdic-6600-58.pdf. 

• https://www.fdic.gov/resources/ 

regulations/federal-registerpublications/2022/fdic-6600-59.pdf. 

Request for Comment 

Comments are invited on: (a) Whether 

the collection of information is 

necessary for the proper performance of 

the FDIC’s functions, including whether 

the information has practical utility; (b) 

the accuracy of the estimates of the 

burden of the information collections, 

including the validity of the 

methodology and assumptions used; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. All comments will become 

a matter of public record. 

Dated at Washington, DC, this 13th day of 

January 2022. 

Federal Deposit Insurance Corporation. 

James P. Sheesley, 

Assistant Executive Secretary. 

[FR Doc. 2022–00983 Filed 1–19–22; 8:45 am] 

BILLING CODE 6714–01–P 

FEDERAL ELECTION COMMISSION 

Sunshine Act Meeting 

FEDERAL REGISTER CITATION NOTICE OF

PREVIOUS ANNOUNCEMENT: 87 FR 781. 

PREVIOUSLY ANNOUNCED TIME AND DATE OF

THE MEETING: Tuesday, January 11, 2022 

at 10:00 a.m. and its continuation at the 

conclusion of the open meeting on 

January 13, 2022. 

CHANGES IN THE MEETING: This meeting 

also discussed: Matters relating to 

internal personnel decisions, or internal 

rules and practices. 

* * * * * 

CONTACT FOR MORE INFORMATION: Judith 

Ingram, Press Officer, Telephone: (202) 

694–1220. 

Authority: Government in the 

Sunshine Act, 5 U.S.C. 552b. 

Laura E. Sinram, 

Acting Secretary and Clerk of the 

Commission. 

[FR Doc. 2022–01111 Filed 1–18–22; 11:15 am] 

BILLING CODE 6715–01–P 

FEDERAL ELECTION COMMISSION 

Sunshine Act Meeting 

TIME AND DATE: Tuesday, January 25, 

2022 at 10:00 a.m. and its continuation 

at the conclusion of the open meeting 

on January 27, 2022. 

PLACE: 1050 First Street NE, 

Washington, DC. (This meeting will be 

a virtual meeting). 

STATUS: This meeting will be closed to 

the public. 

MATTERS TO BE CONSIDERED: Compliance 

matters pursuant to 52 U.S.C. 30109. 

Matters concerning participation in 

civil actions or proceedings or 

arbitration. 

* * * * * 

CONTACT PERSON FOR MORE INFORMATION: 

Judith Ingram, Press Officer. Telephone: 

(202) 694–1220. 

Authority: Government in the 

Sunshine Act, 5 U.S.C. 552b. 

Vicktoria J. Allen, 

Acting Deputy Secretary of the Commission. 

[FR Doc. 2022–01200 Filed 1–18–22; 4:15 pm] 

BILLING CODE 6715–01–P 

FEDERAL RESERVE SYSTEM 

Change in Bank Control Notices; 

Acquisitions of Shares of a Bank or 

Bank Holding Company 

The notificants listed below have 

applied under the Change in Bank 

Control Act (Act) (12 U.S.C. 1817(j)) and 

§ 225.41 of the Board’s Regulation Y (12 

CFR 225.41) to acquire shares of a bank 

or bank holding company. The factors 

that are considered in acting on the 

applications are set forth in paragraph 7 

of the Act (12 U.S.C. 1817(j)(7)). 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in paragraph 7 of 

the Act. 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue, NW, 

Washington, DC 20551–0001, not later 

than February 4, 2022. 

A. Federal Reserve Bank of Chicago 

(Colette A. Fried, Assistant Vice 

President) 230 South LaSalle Street, 

Chicago, Illinois 60690–1414: 

1. Jere M. Ahrens, Jill A. Ahrens and 

Becky C. Campbell, all of Houston, 

Texas; Karen L. Ahrens, North Fort 

Myers, Florida; Jessica A. Ahrens 

Bingaman, Fort Worth, Texas; Lindsay 

S. Ahrens Dahl, Camp Crook, South 

Dakota; Jenna K. Ahrens Brown, 

Laramie, Wyoming; and Brian E. 

Campbell, San Diego, California; to join 

the Ahrens Family Control Group, a 

group acting in concert, to retain voting 

shares of HTB, Inc., and thereby 

indirectly retain voting shares of Home 

Trust & Savings Bank, both of Osage, 

Iowa. 


lotter on DSK11XQN23PROD with NOTICES1
3110 Federal Register / Vol. 87, No. 13 / Thursday, January 20, 2022 / Notices 

Board of Governors of the Federal Reserve 

System, January 14, 2022. 

Ann Misback, 

Secretary of the Board. 

[FR Doc. 2022–01054 Filed 1–19–22; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development Initial 

Review Group; Pediatrics Study Section. 

Date: March 3, 2022. 

Time: 11:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6710B Rockledge Drive, Room 2137B, 

Bethesda, MD 20892 (Video Assisted 

Meeting). 

Contact Person: Joanna Kubler-Kielb, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, Eunice Kennedy Shriver 

National Institute of Child Health and 

Human Development, National Institutes of 

Health, 6710B Rockledge Drive, Room 2137B, 

Bethesda, MD 20892, (301) 435–6916, kielbj@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.865, Research for Mothers 

and Children, National Institutes of Health, 

HHS) 

Dated: January 14, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–01083 Filed 1–19–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Arthritis and 

Musculoskeletal and Skin Diseases Initial 

Review Group; Arthritis and Musculoskeletal 

and Skin Diseases Clinical Trials Study 

Section. 

Date: February 17–18, 2022. 

Time: 9:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Arthritis and 

Musculoskeletal and Skin Diseases, 6701 

Democracy Boulevard, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Kathy Salaita, SCD, Chief, 

Scientific Review Branch, National Institute 

of Arthritis and Musculoskeletal and Skin 

Diseases, 6701 Democracy Boulevard, Suite 

800, Bethesda, MD 20892, 301–594–5033, 

kathy.salaita@nih.gov. 

Name of Committee: Arthritis and 

Musculoskeletal and Skin Diseases Initial 

Review Group; Arthritis and Musculoskeletal 

and Skin Diseases Special Grants Study 

Section. 

Date: February 24–25, 2022. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Arthritis and 

Musculoskeletal and Skin Diseases, 6701 

Democracy Blvd., Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Helen Lin, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institute of Arthritis, 

Musculoskeletal and Skin Diseases, 6701 

Democracy Boulevard, Suite 800, Bethesda, 

MD 20892, 301–594–4952, linh1@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.846, Arthritis, 

Musculoskeletal and Skin Diseases Research, 

National Institutes of Health, HHS) 

Dated: January 13, 2022. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–01027 Filed 1–19–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; PDAC 

Stromal Reprogramming Consortium (PSRC). 

Date: March 3, 2022. 

Time: 11:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W240, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Hasan Siddiqui, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W240, Rockville, 

Maryland 20850, 240–276–5122, 

hasan.siddiqui@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Research 

Centers for Cancer Systems Biology and DCB 

Multi-Consortia Coordinating Center Review. 

Date: March 7–8, 2022. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute at Shady 

Grove, 9609 Medical Center Drive, Room 

7W104, Rockville, Maryland 20850 

(Telephone Conference Call). 

Contact Person: Eun Ah Cho, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W104, Rockville, Maryland 20850, 

240–276–6342, choe@mail.nih.gov. 


lotter on DSK11XQN23PROD with NOTICES1